We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2317:TWSEHon Hai Precision Industry Co., Ltd. Analysis

Data as of 2026-07-21 - not real-time

NT$246.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hon Hai is trading just above its short‑term moving average while remaining below the mid‑term average, indicating a modestly bullish bias despite a neutral overall trend. The RSI hovers around the midpoint, and the MACD histogram has turned positive, reinforcing the slight upside momentum. Volume has been tapering, which could temper short‑term gains, but the price is comfortably above the identified support zone and still has room before hitting the next resistance level.
Fundamentally, the company delivers robust top‑line growth and carries a forward PE that is markedly lower than the industry average, suggesting relative cheapness on a earnings basis. Cash on hand exceeds debt, and the dividend payout ratio is well under fifty percent, supporting the sustainability of its generous yield. Analyst consensus remains bullish with price targets substantially above the current level, although a discounted cash‑flow model flags potential overvaluation, implying that upside may be limited unless margins improve.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD histogram indicating short‑term bullishness
  • Decreasing volume suggesting caution
  • Strong dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst price targets imply significant upside
  • Revenue growth outpacing peers
  • Forward PE well below industry average

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified global footprint reduces single‑region exposure
  • Stable cash generation supports ongoing dividend and investment
  • Secular demand for electronics and emerging automotive components

Key Metrics & Analysis

Financial Health

Revenue Growth28.90%
Profit Margin2.30%
P/E Ratio18.4
ROE11.81%
ROA3.67%
Debt/Equity66.62
P/B Ratio1.9
Op. Cash FlowNT$281.1B
Free Cash FlowNT$37.2B
Industry P/E32.9

Technical Analysis

TrendNeutral
RSI50.1
SupportNT$230.00
ResistanceNT$262.50
MA 20NT$242.33
MA 50NT$256.46
MA 200NT$232.59
MACDBullish
VolumeDecreasing
Fear & Greed Index88.13

Valuation

Fair ValueNT$112.85
Target PriceNT$313.76
Upside/Downside27.55%
GradeFair
TypeBlend
Dividend Yield3.06%

Risk Assessment

Beta0.95
Volatility34.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.